Sera Prognostics Stock Forecast, Price & News

Sera Prognostics (NASDAQ:SERA) Frequently Asked Questions

Is Sera Prognostics a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sera Prognostics in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Sera Prognostics stock.
View analyst ratings for Sera Prognostics or view top-rated stocks.

Are investors shorting Sera Prognostics?

Sera Prognostics saw a increase in short interest in the month of October. As of October 29th, there was short interest totaling 162,000 shares, an increase of 38.5% from the October 14th total of 117,000 shares. Based on an average daily volume of 67,000 shares, the days-to-cover ratio is currently 2.4 days. Currently, 1.8% of the shares of the stock are sold short.
View Sera Prognostics' Short Interest.

When is Sera Prognostics' next earnings date?

Sera Prognostics is scheduled to release its next quarterly earnings announcement on Tuesday, February 8th 2022.
View our earnings forecast for Sera Prognostics.

How were Sera Prognostics' earnings last quarter?

Sera Prognostics Inc (NASDAQ:SERA) released its quarterly earnings data on Tuesday, November, 9th. The company reported ($0.39) EPS for the quarter, missing the consensus estimate of ($0.22) by $0.17. The firm earned $0.02 million during the quarter, compared to analyst estimates of $0.08 million.
View Sera Prognostics' earnings history.

What price target have analysts set for SERA?

4 equities research analysts have issued 12 month price targets for Sera Prognostics' stock. Their forecasts range from $18.00 to $19.00. On average, they anticipate Sera Prognostics' stock price to reach $18.50 in the next year. This suggests a possible upside of 77.7% from the stock's current price.
View analysts' price targets for Sera Prognostics or view top-rated stocks among Wall Street analysts.

Who are some of Sera Prognostics' key competitors?

Some companies that are related to Sera Prognostics include Castle Biosciences (CSTL), Genetron (GTH), Renalytix AI (RNLX), Personalis (PSNL), DermTech (DMTK), Progenity (PROG), Viridian Therapeutics (VRDN), Celcuity (CELC), Exagen (XGN), Enzo Biochem (ENZ), Centogene (CNTG), Biocept (BIOC), OpGen (OPGN), Vyant Bio (VYNT) and Psychemedics (PMD).
View all of SERA's competitors.

When did Sera Prognostics IPO?

(SERA) raised $75 million in an initial public offering on Thursday, July 15th 2021. The company issued 4,687,500 shares at $15.00-$17.00 per share.

What is Sera Prognostics' stock symbol?

Sera Prognostics trades on the NASDAQ under the ticker symbol "SERA."

When does the company's lock-up period expire?

Sera Prognostics' lock-up period expires on Tuesday, January 11th. Sera Prognostics had issued 4,687,500 shares in its IPO on July 15th. The total size of the offering was $75,000,000 based on an initial share price of $16.00. After the expiration of the company's lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted.

Who are Sera Prognostics' major shareholders?

Sera Prognostics' stock is owned by many different retail and institutional investors. Top institutional investors include Interwest Venture Management Co. (8.25%), Bill & Melinda Gates Foundation (2.66%), Millennium Management LLC (0.55%), BlackRock Inc. (0.51%), Tudor Investment Corp Et Al (0.22%) and Citadel Advisors LLC (0.19%).

Which major investors are buying Sera Prognostics stock?

SERA stock was acquired by a variety of institutional investors in the last quarter, including Interwest Venture Management Co., Bill & Melinda Gates Foundation, Millennium Management LLC, BlackRock Inc., Tudor Investment Corp Et Al, Citadel Advisors LLC, Geode Capital Management LLC, and Squarepoint Ops LLC.

How do I buy shares of Sera Prognostics?

Shares of SERA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sera Prognostics' stock price today?

One share of SERA stock can currently be purchased for approximately $10.41.

How much money does Sera Prognostics make?

Sera Prognostics has a market capitalization of $304.95 million.

How many employees does Sera Prognostics have?

Sera Prognostics employs 2,021 workers across the globe.

What is Sera Prognostics' official website?

The official website for Sera Prognostics is www.seraprognostics.com.

How can I contact Sera Prognostics?

The company can be reached via email at [email protected].